$87.350
-5.171 (-5.92%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de HNGE por análisis de gráficos similares
Alphio's HNGE stock price prediction model matches the current Hinge Health Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $89.72 (+2.71%). The 1-week path is $88.16 (+0.93%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Hinge Health Inc?
Hinge Health Inc is a good buy right now due to its strong revenue guidance, which was raised to between $856 million and $860 million, exceeding consensus estimates of $822.16 million. Additionally, the company reported a significant year-over-year revenue growth of 53% in Q2 2026, reaching $213 million, and a gross margin of 86.44%, showcasing its profitability. The main risk is the current RSI of 44.033, indicating a potential oversold condition, but the overall positive catalysts outweigh this concern.
HNGE cerró en $87.35 el Friday, tras bajar -5.92%
Hinge Health Inc (HNGE) last closed at $87.35, losing -5.92%. These facts feed the 1-day and 1-week HNGE price prediction above.
Factores de la previsión
Los factores de la previsión de Hinge Health Inc (HNGE) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de HNGE, ordenadas por similitud.
Análisis de estacionalidad de HNGE
Historically the probability of a positive August return for HNGE is 100.00%. June offers the highest probability of a positive month at 100.00%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.